Patient Selection Matters: Prognostic Determinants in Stage IV Colorectal Cancer With Isolated Non-Regional Lymph Node Metastasis.

Authors

Fu-Chieh Hsu, Po-Kai Chan, Yu-Ching Chou, Chi-Wei Yang, Yi-Ting Chou, Sung-Hua Chiu, Yi-Chiao Cheng

Published in

The American surgeon. Pages 31348261474181. Jul 29, 2026. Epub Jul 29, 2026.

Abstract

BackgroundColorectal cancer (CRC) with isolated non-regional lymph node metastasis (INRLNM) is a rare entity, accounting for <1% of metastatic cases. While systemic therapy is the standard treatment, the benefit of surgical intervention remains controversial. Consequently, this retrospective study evaluates the impact of palliative surgery and treatment sequencing on patient prognosis.MethodsFifty patients diagnosed with stage IV CRC and INRLNM were included. Patients were further categorized into treatment subgroups, including chemotherapy-alone (CA), best supportive care, and a surgery group. The surgery group was subdivided into surgery-first (SF) and neoadjuvant chemotherapy subgroups with or without lymph node regression. Overall survival (OS) and progression-free survival (PFS) were evaluated using Kaplan-Meier analyses and Cox proportional hazards models.ResultsWhile Kaplan-Meier analyses indicated superior OS and PFS in the surgery group compared to the CA group (P < .05), multivariate Cox regression revealed that surgical intervention was not an independent predictor of survival. Subgroup analyses showed no survival differences based on neoadjuvant chemotherapy sequencing or lymph node regression. Instead, ASA grade III, right-sided cancer, and surgical complications were independently associated with worse outcomes.DiscussionSurgical intervention was not independently associated with a survival benefit in this patient population. However, our findings suggest that neoadjuvant chemotherapy followed by surgery may exhibit a more favorable trend in overall survival. Given the rarity of this metastatic pattern, further large-scale studies are essential to clarify and establish optimal treatment strategies for these patients.

PMID:
42527876
Bibliographic data and abstract were imported from PubMed on 30 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.